Feedback / Questions
Elayta (CT1812) - Cognition Therap
https://www.globenewswire.com/news-release/2024/04/29/2871142/0/en/Cognition-Therapeutics-Completes-Enrollment-in-Phase-2-SHIMMER-Study-of-CT1812-in-Mild-to-Moderate-Dementia-with-Lewy-Bodies.html
Apr 29, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next